EUVIMEDScopri EUVIMED
Kohortenstudie

Impact of Peri‐Procedural Red Blood Cell Transfusion on Clinical Outcomes in Transcatheter Aortic Valve Replacement: A Propensity‐Matched Cohort Study

Abdul Qadeer, Michele Fouad, Muneeb Khawar, Muhammad Haris Khan, Najam Gohar, Kamel Ikbariah, Qasim Bashir iD, Muhammad Umer Ishaq iD, Awon Muhammad, Shameer Iqbal Ghuman, Elham Shenawa iD, Mirza Muhammad Hadeed Khawar iD and 4 more

Catheterization and Cardiovascular Interventions · 2026-05 · 107 (6) · 1835-1846

DOI: 10.1002/ccd.70554 ↗

At a glance

Kohortenstudie in Catheterization and Cardiovascular Interventions, published online on 2026-03-09. Written by Abdul Qadeer and 15 co-authors. Institution: The University of Texas Medical Branch, Galveston, Texas, USA. Major MEDLINE topics: Erythrocyte Transfusion, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis. Cited 1 times so far (Crossref); 32 references. Funded by: NCATS NIH HHS.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Red blood cell (RBC) transfusion is common after transcatheter aortic valve replacement (TAVR) to manage peri‐procedural bleeding and has been associated with adverse outcomes in various studies. However, the prognostic impact of peri‐procedural transfusion in TAVR patients remains unclear. This study aimed to assess the impact of peri‐procedural RBC transfusion on cardiovascular outcomes in TAVR patients compared to those without transfusion.

Methods

A retrospective cohort study was conducted using the TriNetX US Collaborative Research Network, including adults undergoing TAVR until August 31, 2025. Patients were divided into those receiving RBC transfusion ( n = 3,176) and those without ( n = 79,664) on the day of receiving TAVR. Propensity score matching (1:1) balanced cohorts ( n = 3161 each) for demographics, comorbidities, medications, and laboratory values. Relative risks (RR) and hazard ratios (HR) were calculated using propensity‐matched and Cox proportional hazard models.

Results

Transfused patients had significantly higher all‐cause mortality (RR 3.933; 95% CI: 2.27−6.92; p < 0.001 at 7 days; RR 1.824; 95% CI: 1.466−2.268; p < 0.001 at 3 months). Secondary outcomes showed elevated risks for MACE (RR 1.324; 95% CI: 1.073−1.633; p = 0.009 at 7 days; RR 1.199; 95% CI: 1.060−1.358; p = 0.004 at 3 months), hemodynamic instability (RR 2.063; 95% CI: 1.655−2.571; p < 0.001 at 7 days; RR 1.638; 95% CI: 1.368−1.962; p < 0.001 at 3 months), acute kidney injury (RR 1.615; 95% CI: 1.295‐2.013; p < 0.001 at 7 days; RR 1.379; 95% CI: 1.196−1.591; p < 0.001 at 3 months), and post‐TAVR sepsis (RR 1.184; 95% CI: 0.771−1.819; p = 0.439 at 30 days; RR 0.899; 95% CI: 0.667−1.211; p = 0.483 at 3 months). Ischemic stroke/TIA risk was modestly increased in unadjusted analyses but attenuated post‐matching (RR 1.123; 95% CI: 0.823−1.534; p = 0.464 at 7 days; RR 1.219; 95% CI: 0.995−1.493; p = 0.056 at 3 months). Cox models showed statistically significant risk elevations for most outcomes, including heart failure exacerbation (HR 1.418; 95% CI: 1.311−1.533; p < 0.001).

Conclusions

Peri‐procedural RBC transfusion was associated with increased risks of mortality and complications after TAVR, with attenuation over time. These findings support consideration of restrictive transfusion strategies.

Subjects

MeSH terms (MEDLINE)

Erythrocyte TransfusionTranscatheter Aortic Valve ReplacementAortic Valve StenosisHumansFemaleRetrospective StudiesRisk FactorsTreatment OutcomeMaleTime FactorsAged, 80 and overRisk AssessmentAgedPropensity ScoreDatabases, Factual

Author keywords

anemia, propensity score matchingmajor adverse cardiovascular events (MACE)mortalityperi‐procedural bleedingred blood cell transfusiontranscatheter aortic valve replacement

Authors and institutions

  • The University of Texas Medical Branch, Galveston, Texas, USA.
  • Alexandria Faculty of Medicine, Alexandria, Egypt.
  • King Edward Medical University, Lahore, Pakistan.
  • Louisiana State University, Baton Rouge, Louisiana, USA.
  • Ameer-Ud-Din Medical College, Lahore, Pakistan.
  • Lahey Hospital and Medical Center, Burlington Massachusetts, USA.

ORCID profiles: Qasim Bashir, Muhammad Umer Ishaq, Elham Shenawa, Mirza Muhammad Hadeed Khawar, Hani Jneid

Funding

  • NCATS NIH HHS

Cite

APA

Qadeer, A., Fouad, M., Khawar, M., Khan, M. H., Gohar, N., Ikbariah, K., Bashir, Q., Ishaq, M. U., Muhammad, A., Iqbal Ghuman, S., Shenawa, E., Khawar, M. M. H., Gaalema, D., Jneid, H., Shalaby, M., & Mortada, I. (2026). Impact of Peri‐Procedural Red Blood Cell Transfusion on Clinical Outcomes in Transcatheter Aortic Valve Replacement: A Propensity‐Matched Cohort Study. Catheterization and Cardiovascular Interventions, 107(6), 1835-1846. https://doi.org/10.1002/ccd.70554

Vancouver

Qadeer A, Fouad M, Khawar M, Khan MH, Gohar N, Ikbariah K, et al. Impact of Peri‐Procedural Red Blood Cell Transfusion on Clinical Outcomes in Transcatheter Aortic Valve Replacement: A Propensity‐Matched Cohort Study. Catheterization and Cardiovascular Interventions. 2026;107(6):1835-1846. doi:10.1002/ccd.70554

BibTeX
@article{Qadeer2026,
  author = {Qadeer, Abdul and Fouad, Michele and Khawar, Muneeb and Khan, Muhammad Haris and Gohar, Najam and Ikbariah, Kamel and Bashir, Qasim and Ishaq, Muhammad Umer and Muhammad, Awon and Iqbal Ghuman, Shameer and Shenawa, Elham and Khawar, Mirza Muhammad Hadeed and Gaalema, Diann and Jneid, Hani and Shalaby, Mostafa and Mortada, Ibrahim},
  title = {Impact of Peri‐Procedural Red Blood Cell Transfusion on Clinical Outcomes in Transcatheter Aortic Valve Replacement: A Propensity‐Matched Cohort Study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {107},
  number = {6},
  pages = {1835--1846},
  doi = {10.1002/ccd.70554}
}
Start for free →